High Potent Active Pharmaceutical Ingredients(HPAPI) Manufacturing

With over decades of experience, Dr. Reddy's specializes in developing and manufacturing High Potent Active Pharmaceutical Ingredients (HPAPI). We offer HPAPIs manufactured in our FDA inspected cGMP API manufacturing facilities with comprehensive containment processes (up to OEL 0.1µg/m³) and diligent QC/QA.

Dr. Reddy’s Approach in Handling HPAPIs

Reddy’s approach for high-potent APIs involves the following process:

Dr. Reddy’s
Approach in
Handling
HPAPIs

01.Evaluating the hazard of exposure to a compound and calculating the OEL levels

02.Selecting the appropriate containment strategy for development and manufacturing based on scale

03.Choosing proper engineering controls such as ventilation, chemical contaminants, etc.

04.Selecting the appropriate equipment and procedures, including PPE Sampling & weighing, blending, and drying

05.Define Packaging needs to meet the requirements Capsule/Blistering Injectables

We are here to help, if you have any country specific requirements.

From initial stages of development to commercialization, our team of scientists, quality, regulatory, supply chain, and analytical experts work collaboratively to meet our global clients' HPAPI requirements.

As an integrated HPAPI supplier, we have best-in-class cGMP manufacturing facilities for APIs and finished dosage forms. With our integrated R&D capabilities and infrastructure, we are well-positioned to support our customers to bring their products to the market faster. In addition, our rigorous safety, health, and environmental (SHE) practices, together with Occupational Exposure Band (OEB) and Occupational Exposure Limit (OEL) based controls, are established to protect workers, materials, machines, and the environment.

Facilities for handling HPAPIs

Dr. Reddy’s can handle molecules of OEL up to 0.1 µg/m3 at the following facilities:

cGMP compliant isolator systems (OEL 0.1µg/m³) for high potent raw materials, intermediates charging, filtration and drying, dispensing and packaging
Reaction mass transfer through closed loop lines
Rapid transfer ports for solid material transfer
HVAC system with zone classification to avoid cross-contamination
EPA filtered air
Multiple utilities (cooling tower water, hot water, chilled brine, nitrogen, compressed air & steam
Differential pressure system with temperature and humidity control

Contact Us

Please fill out the following form. We will get back to you shortly.

Eu concordo e aceito a Política de Privacidade e os Termos de Uso deste site.

Envie-nos um email: api@drreddys.com | +91 40 49002222

FAQs

We offer HPAPIs manufactured in our FDA inspected cGMP API manufacturing facilities with comprehensive containment processes (up to OEL 0.1µg/m³) and diligent QC/QA.

With over decades of experience, Dr. Reddy's specializes in developing and manufacturing High Potent Active Pharmaceutical Ingredients (HPAPI).

Our manufacturing sites are complemented by our analytical cGMP labs for QC and QA.

Manufacturing plants are regularly inspected/audited by international regulatory authorities and numerous customers.

We enable the best safety and healthy environmental practices through Occupational Exposure Band (OEB) and Occupational Exposure Limit (OEL) based controls for workers, material, machines, and environment.

Top-class safety practices and containment control strategy in place.

HVAC system with zone classification to avoid cross-contamination
Choosing proper engineering controls such as ventilation, chemical contaminants, etc

Aviso Legal

Nenhuma informação neste site, incluindo qualquer referência a qualquer produto ou serviço, constitui uma oferta de venda ou pode ser interpretada como representando uma oferta de venda. Produtos protegidos por patentes válidas não são oferecidos ou fornecidos para uso comercial. No entanto, em certos casos, a critério exclusivo do Dr. Reddy e sujeito a requisitos legais locais, as quantidades de pesquisa de tais produtos podem ser oferecidas para fins de submissões regulatórias sob a Seção 107A da Lei de Patentes da Índia (isenção Bolar), onde quer que tais isenções regulatórias existam. Os compradores devem fazer sua avaliação independente do produto ou serviço, incluindo o cenário de patentes em seus respectivos mercados e serão responsáveis por todas as responsabilidades relacionadas a patentes. O Dr. Reddy se isenta de todas as garantias, expressas ou implícitas, incluindo, entre outras, garantias de comercialização, adequação a uma finalidade específica e não violação.

Let’s talk API sourcing live at

Tackle sourcing bottlenecks and compliance hurdles

Hall E1 Booth H28 24-26 June 2025, Shanghai

Book a Meeting